These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 2431166
21. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Plagemann PG. Virology; 2001 Nov 10; 290(1):11-20. PubMed ID: 11882995 [Abstract] [Full Text] [Related]
22. Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D. Van der Ploeg JR, Drijfhout JW, Feijlbrief M, Bloemhoff W, Welling GW, Welling-Wester S. J Immunol Methods; 1989 Nov 30; 124(2):211-7. PubMed ID: 2480978 [Abstract] [Full Text] [Related]
23. Protection against feline leukemia virus infection by use of an inactivated virus vaccine. Hoover EA, Perigo NA, Quackenbush SL, Mathiason-DuBard CK, Overbaugh JM, Kloetzer WS, Elder JH, Mullins JI. J Am Vet Med Assoc; 1991 Nov 15; 199(10):1392-401. PubMed ID: 1666090 [Abstract] [Full Text] [Related]
24. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. Richardson J, Fossati I, Moraillon A, Castelot S, Sonigo P, Pancino G. J Gen Virol; 1996 Apr 15; 77 ( Pt 4)():759-71. PubMed ID: 8627265 [Abstract] [Full Text] [Related]
26. Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae. Peterson EM, Cheng X, Qu Z, de La Maza LM. Infect Immun; 1996 Aug 15; 64(8):3354-9. PubMed ID: 8757875 [Abstract] [Full Text] [Related]
27. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. López JA, Andreu D, Carreño C, Whyte P, Taylor G, Melero JA. J Gen Virol; 1993 Dec 15; 74 ( Pt 12)():2567-77. PubMed ID: 7506298 [Abstract] [Full Text] [Related]
28. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes. Alvarenga LM, Diniz CR, Granier C, Chávez-Olórtegui C. Toxicon; 2002 Jan 15; 40(1):89-95. PubMed ID: 11602284 [Abstract] [Full Text] [Related]
29. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection. Deng K, Liu R, Rao H, Jiang D, Wang J, Xie X, Wei L. PLoS One; 2015 Jan 15; 10(9):e0138756. PubMed ID: 26406225 [Abstract] [Full Text] [Related]
30. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Plagemann PG. Vet Immunol Immunopathol; 2004 Dec 08; 102(3):263-75. PubMed ID: 15507310 [Abstract] [Full Text] [Related]
31. Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera. Bayer H, Hunsmann G. J Gen Virol; 1987 Feb 08; 68 ( Pt 2)():515-22. PubMed ID: 3469323 [Abstract] [Full Text] [Related]
32. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas. Carrow EW, Vujcic LK, Glass WL, Seamon KB, Rastogi SC, Hendry RM, Boulos R, Nzila N, Quinnan GV. AIDS Res Hum Retroviruses; 1991 Oct 08; 7(10):831-8. PubMed ID: 1720630 [Abstract] [Full Text] [Related]
33. Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus. Kumar DV, Berry BT, Roy-Burman P. J Virol; 1989 May 08; 63(5):2379-84. PubMed ID: 2539525 [Abstract] [Full Text] [Related]
34. Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Yuasa S, Cheung RC, Pham Q, Robinson WS, Marion PL. Virology; 1991 Mar 08; 181(1):14-21. PubMed ID: 1704654 [Abstract] [Full Text] [Related]
35. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Vedbrat SS, Rasheed S, Lutz H, Gonda MA, Ruscetti S, Gardner MB, Prensky W. Virology; 1983 Jan 30; 124(2):445-61. PubMed ID: 6186079 [Abstract] [Full Text] [Related]
36. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. Tanaka Y, Tanaka R, Terada E, Koyanagi Y, Miyano-Kurosaki N, Yamamoto N, Baba E, Nakamura M, Shida H. J Virol; 1994 Oct 30; 68(10):6323-31. PubMed ID: 8083972 [Abstract] [Full Text] [Related]
37. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. Weijer WJ, Drijfhout JW, Geerligs HJ, Bloemhoff W, Feijlbrief M, Bos CA, Hoogerhout P, Kerling KE, Popken-Boer T, Slopsema K. J Virol; 1988 Feb 30; 62(2):501-10. PubMed ID: 2826811 [Abstract] [Full Text] [Related]
38. Fine mapping of bovine herpesvirus-1 (BHV-1) glycoprotein D (gD) neutralizing epitopes by type-specific monoclonal antibodies and sequence comparison with BHV-5 gD. Abdelmagid OY, Minocha HC, Collins JK, Chowdhury SI. Virology; 1995 Jan 10; 206(1):242-53. PubMed ID: 7530392 [Abstract] [Full Text] [Related]
39. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU. Burkhart MD, Kayman SC, He Y, Pinter A. J Virol; 2003 Apr 10; 77(7):3993-4003. PubMed ID: 12634359 [Abstract] [Full Text] [Related]
40. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein. Callebaut I, Burny A, Krchnák V, Gras-Masse H, Wathelet B, Portetelle D. Virology; 1991 Nov 10; 185(1):48-55. PubMed ID: 1718088 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]